ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Pharmaceuticals

Takeda works on drug to treat COVID complications

Universities collaborate on medicine that might prevent blood vessel inflammation

Researchers at Takeda Pharmaceutical and two Japanese universities hope to bring their drug to market in a few years.

TOKYO -- Takeda Pharmaceutical and two Japanese universities are developing a drug to treat the clogging and inflammation of blood vessels, complications of COVID-19.

The drug uses a mechanism different from those of existing coronavirus drugs, and the developers report that it will likely help prevent the aggravation of COVID-19 symptoms.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more